Literature DB >> 16286098

Prevalence, diagnosis, characterization, and treatment of prostatitis, interstitial cystitis, and epididymitis in outpatient urological practice: the Canadian PIE Study.

J Curtis Nickel1, Joel M H Teichman, Mireille Gregoire, Janet Clark, Joe Downey.   

Abstract

OBJECTIVES: To determine the prevalence, diagnostic patterns, and management of prostatitis, interstitial cystitis, and epididymitis (PIE) in Canadian urology outpatient practice.
METHODS: Representative urologists were randomly selected from the Canadian and Quebec Urological Associations. Each patient identified with a PIE diagnosis during a typical 2-consecutive-week period during April 2004 to July 2004 was requested to complete a corresponding Chronic Prostatitis Symptom Index (CPSI), O'Leary-Sant Symptom Index (OSSI), or a Chronic Epididymitis Symptom Index (CESI). Each day the participant urologist completed an outpatient log and a detailed programmed chart review to transcribe demographics, investigations, and treatments associated with each PIE patient.
RESULTS: Sixty-five urologists were invited to participate. Fifty-seven (88%) agreed, and 48 (74%) completed the audit. Of the 8712 patients seen in outpatient practice (average 182 per urologist), 2675 were female and 6037 male. Prostatitis was identified in 2.7% of the men (n = 166; mean age 50 years; mean duration 3.1 years; mean CPSI score 19.7), interstitial cystitis in 2.8% of patients (n = 242; 211 women [7.9%], 26 men [0.4%]; mean age 50.2 years, mean duration 4.5 years, mean OSSI score 11.8), and epididymitis in 0.9% of men (n = 57; mean age 41.1 years, mean duration 2.5 years, mean CESI score 15.5). There was wide variance in investigations and treatments.
CONCLUSIONS: This prospective audit indicates that prostatitis might not be as common as frequently believed and that interstitial cystitis is more common, and it represents the first estimate of the prevalence of epididymitis in urologic practice. The wide variance in investigations and treatments confirms the need for practice management guidelines.

Entities:  

Mesh:

Year:  2005        PMID: 16286098     DOI: 10.1016/j.urology.2005.05.007

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  35 in total

1.  Prostatitis.

Authors:  J Curtis Nickel
Journal:  Can Urol Assoc J       Date:  2011-10       Impact factor: 1.862

2.  Hunner's lesions.

Authors:  Joel M H Teichman
Journal:  Can Urol Assoc J       Date:  2009-12       Impact factor: 1.862

3.  Nutraceuticals in Prostate Disease: The Urologist's Role.

Authors:  J Curtis Nickel; Daniel Shoskes; Claus G Roehrborn; Mark Moyad
Journal:  Rev Urol       Date:  2008

4.  Correlates of Health Care Seeking Activities in Patients with Urological Chronic Pelvic Pain Syndromes: Findings from the MAPP Cohort.

Authors:  J Quentin Clemens; Alisa Stephens-Shields; Bruce D Naliboff; H Henry Lai; Larissa Rodriguez; John N Krieger; David A Williams; John W Kusek; J Richard Landis
Journal:  J Urol       Date:  2018-01-04       Impact factor: 7.450

Review 5.  [Orchitis and male infertility].

Authors:  H-C Schuppe; A Pilatz; H Hossain; A Meinhardt; M Bergmann; G Haidl; W Weidner
Journal:  Urologe A       Date:  2010-05       Impact factor: 0.639

6.  Alpha-blockers for the treatment of prostatitis-like syndromes.

Authors:  J Curtis Nickel
Journal:  Rev Urol       Date:  2006

7.  Regulation and functional impact of lipopolysaccharide induced Nod2 gene expression in the murine epididymal epithelial cell line PC1.

Authors:  Marcus Mühlbauer; Adam W Cheely; Suresh Yenugu; Christian Jobin
Journal:  Immunology       Date:  2008-02-12       Impact factor: 7.397

Review 8.  [Interstitial cystitis. An important differential diagnosis].

Authors:  A van Ophoven; F Oberpenning
Journal:  Urologe A       Date:  2006-04       Impact factor: 0.639

Review 9.  Paediatric painful bladder syndrome/interstitial cystitis: diagnosis and treatment.

Authors:  Jason Sea; Joel M H Teichman
Journal:  Drugs       Date:  2009       Impact factor: 9.546

10.  Gender-based reciprocal expression of transforming growth factor-beta1 and the inducible nitric oxide synthase in a rat model of cyclophosphamide-induced cystitis.

Authors:  Pradeep Tyagi; Vikas Tyagi; Naoki Yoshimura; Erich Witteemer; Derek Barclay; Patricia A Loughran; Ruben Zamora; Yoram Vodovotz
Journal:  J Inflamm (Lond)       Date:  2009-08-19       Impact factor: 4.981

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.